ArticleMedicine2026
Machine learning and bioinformatics-based identification of mitophagy-related diagnostic biomarkers in bronchiolitis obliterans.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to explore the molecular mechanisms associated with mitophagy in BO and identified mitophagy-associated BO diagnostic genes. Using Gene Expression Omnibus database data, differentially expressed genes in BO patients vs controls were analyzed via Gene Ontology enrichment. Algorithms like Boruta, least absolute shrinkage and selection operator, and Random Forest screened BO-specific genes. Mitophagy genes were sourced from PathCards and correlated with BO-specific genes via single-sample gene set enrichment analysis (ssGSEA). Receiver operating characteristic curves evaluated the diagnostic performance of these genes. Two hundred and six differentially expressed genes were identified, in which immune-related pathways such as the B-cell receptor signaling pathway and lymphocyte differentiation were significantly enriched. Machine learning screening yielded 30 BO signature genes, among which KLRC3 and CD36 were significantly correlated with ssGSEA enrichment score of the mitophagy gene sets. Receiver operating characteristic analysis confirmed their diagnostic value with AUCs of 0.648 and 0.640, respectively. This finding indicated that KLRC3 and CD36 are not only significantly correlated with ssGSEA enrichment score of the mitophagy gene sets but also have diagnostic value for BO.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.